XTANT MEDICAL HOLDINGS, INC. (XTNT) Net margin 2016–2025
XTANT MEDICAL HOLDINGS, INC. (XTNT) net profit margin by fiscal year — reported net income divided by reported revenue.
3.7%FY2025 · since FY2016: -21.7% → 3.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3.7% | +17.7 pp |
| FY2024 | -14.0% | -14.7 pp |
| FY2023 | 0.7% | +15.4 pp |
| FY2022 | -14.6% | -5.9 pp |
| FY2021 | -8.8% | +4.4 pp |
| FY2020 | -13.2% | -0.5 pp |
| FY2019 | -12.7% | +84.4 pp |
| FY2018 | -97.1% | -33.6 pp |
| FY2017 | -63.4% | -41.8 pp |
| FY2016 | -21.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More XTNT financial trends
XTNT RevenueXTNT Net incomeXTNT Gross profitXTNT Gross marginXTNT Operating incomeXTNT Operating marginXTNT Operating cash flowXTNT Free cash flowXTNT Capital expendituresXTNT Return on equityXTNT Stock buybacksXTNT Dividends paidXTNT Total assetsXTNT Total liabilitiesXTNT Shareholders’ equityXTNT overview →